Tracer, QIAGEN Partner on Blood-Based MRD Test for Tumors
June 7, 2025
Tracer Biotechnologies, a leader in blood-based molecular diagnostics for cancer, is pleased to announce a strategic partnership with QIAGEN to co-develop and commercialize minimal residual